CHGX
AXS Change Finance ESG ETF
CHGX tracks an index of 100 US large-cap stocks that meet diverse environmental, social, and governance standards.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 171.9 M
ASSETS UNDER MGMT
49 bp
EXPENSES
Fund Basics
| Inception date | Oct 09, 2017 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Annually |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| ACCENTURE PLC-CL A | 1.4 % |
| SANCHEZ ENERGY CORP | 1.2 % |
| ELI LILLY & CO | 1.2 % |
| INTUITIVE SURGICAL INC | 1.2 % |
| AMGEN INC | 1.2 % |
| WAYFAIR INC- CLASS A | 1.2 % |
| ROPER TECHNOLOGIES, INC. | 1.2 % |
| ULTA BEAUTY INC | 1.2 % |
| CAROLINA TRUST BANCSHARES, INC. | 1.2 % |
| AUTODESK INC | 1.1 % |
Constituent Breakdown
| Number of holdings | 100 |
| Herfindahl-Hirschman Index | 100 |
| Wgt avg mkt cap (mns) | $250,568 |
| Large cap (>$10bn) | 94.1% |
| Mid cap ($2-10bn) | 3.3% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 99.3% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 91.5 % |
 |
IRELAND | 4.1 % |
 |
AUSTRALIA | 1.0 % |
 |
SINGAPORE | 0.8 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 21.3% | 20.8% | 15.5% | 20.1% | 9.5% | -- | -- | 12.3% |
| Dividend Yield | 0.0% | 0.8% | 0.9% | 1.0% | 0.9% | -- | -- | 1.0% |
| Total Returns | 21.3% | 21.6% | 16.3% | 21.1% | 10.5% | -- | -- | 13.3% | Ann. Volatility | 15.8% | 15.3% | 16.6% | 15.5% | 35.6% | -- | -- | 39.1% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.05 | 78% |
| MSCI EAFE | 0.71 | 54% |
| MSCI Emg Mkts | 0.44 | 53% |
Liquidity Measures
| Avg. volume (000) | 14 |
| ADV traded (mns) | $0 |
| Turnover | 0.3% |
| Avg. Bid/Ask (% of price) | 0.03% |
Technical Indicators
| 30d moving avg. (EMA) | $33.37 |
| Relative strength (RSI) | 48 |
| MACD/Signal | -0.01/0.05 |
| Bollinger Bands (Upper/Lower) | $34.07/$32.84 |
| Short interest (% of AUM) | 0.2% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. CHGX |
Expenses vs. CHGX |
ALTAR Score™ vs. CHGX |
|---|---|---|---|---|
| EQWL | Invesco S&P 100 Equal Weight ETF | 37.8% | -19 bp | +0.9% |
| ESMV | iShares ESG MSCI USA Min Vol Factor ETF | 34.7% | -31 bp | +0.4% |
| USMV | iShares MSCI USA Min Vol Factor ETF | 33.3% | -34 bp | +0.6% |
| RSPT | Invesco S&P 500 Equal Weight Technology ETF | 31.5% | -9 bp | +1.0% |
| JQTY | Jensen U.S. Quality Index ETF | 30.7% | -24 bp | +1.1% |
| USXF | iShares ESG Advanced MSCI USA ETF | 29.9% | -39 bp | +0.4% |
| QQQE | Direxion NASDAQ-100 Equal Weighted Index Shares | 29.6% | -14 bp | -0.9% |
| QEW | Invesco QQQ Equal Weight ETF | 29.5% | -24 bp | -0.8% |
| RAFE | PIMCO RAFI ESG U.S. ETF | 29.4% | -19 bp | +1.6% |
| ROE | Astoria US Quality Kings ETF | 29.2% | 0 bp | +1.8% |
Risk and Returns: CHGX vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 11/6/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
5.2%
ALTAR SCORE™
42nd
PERCENTILE
NEUTRAL
ETFRC RATING
There are 1,388 funds in the US Equity category with an average
ALTAR Score™ of 5.7% and a standard deviation
of 2.1%. CHGX's ALTAR Score™ is approximately -0.2 standard
deviations above the category average. This places CHGX in the 42nd percentile
among funds in the category.
Sell-Side Consensus
$39.67
PRICE TARGET
+23.6%
UPSIDE